MedPath
NMPA Approval

Ozagrel Sodium Injection

国药准字H20067343

February 24, 2022

国药准字H20067343

Drug Information

奥扎格雷钠注射液

注射剂

4ml:80mg

化学药品

February 24, 2022

Company Information

Applicant Company

山西省晋中市山西示范区晋中开发区汇通产业园园区8号路

Manufacturing Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.